DaVita Announces 2017 Capital Markets Day

DENVER, April 28, 2017 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced that it will hold its Capital Markets Day in New York City on Thursday, May 25, 2017, from 8:30 a.m. to noon Eastern Time. The event will be held at:

Lotte New York Palace
455 Madison Avenue at 50th Street
New York, NY 10022

If you plan to attend in person, please register online at investors.davita.com

Conference Call & Webcast 
Capital Markets Day will be broadcast live via conference call and webcast. If you are joining by conference call, please provide the passcode "4947561". Investors who are unable to listen live will be able to access the presentation and an audio replay via our web site at investors.davitahealthcarepartners.com. There will be no telephone replay. You may join this call on:

Thursday, May 25, 2017
8:30 a.m. to 11:30 a.m. Eastern Time
Dial in number: 877-918-6630
International dial in: 517-308-9087
Passcode: 4947561

About DaVita Inc.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners, a DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of December 31, 2016, DaVita Kidney Care operated or provided administrative services at 2,350 outpatient dialysis centers located in the United States serving approximately 188,000 patients. The company also operated 154 outpatient dialysis centers located in 11 countries outside the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks in California, Nevada, New Mexico, Florida, Colorado and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of December 31, 2016, HealthCare Partners provided integrated care management for approximately 749,000 patients. For more information, please visit DaVita.com/about.

Investor Contact:
Jim Gustafson


SOURCE DaVita Inc.